French firm Juisci, which uses AI to simplify and deliver reliable, digestible medical research updates for healthcare professionals and organizations, has raised €5.5 million from Big Pi Ventures, Ring Capital, Bpifrance, Wendel, SUPER CAPITAL, and Colloquium.
- Launched in 2021 by Robin Roumengas and David Luu, Juisci develops an AI-powered platform that curates, summarizes, translates, and delivers medical research to healthcare professionals and organizations across over 20 specialties.
- The platform provides digestible summaries, article recommendations, videos, podcasts, and infographics, helping over 200,000 professionals in 60 countries save up to 8 hours a week while staying on top of the latest research. Its AI suite, including JuisciGPT, enables users to explore curated studies, interact with their own publications, and break down knowledge silos.
"Our mission is bold yet clear: simplifying science for those who need it most. We believe exploring medical research should feel as intuitive and engaging as streaming your favorite content. After all, every piece of science carries the power to save clinicians time, strengthen education, and ultimately transform patient outcomes," Juisci's team, commented on LinkedIn.
- Over four years, Juisci has gained 30+ major clients, including Sanofi, UCB, Takeda, bioMérieux, Johnson & Johnson, Air Liquide, L’Oréal, Opella, Royal Canin, hospitals, and scientific societies such as the National Academy of Surgery, Dijon University Hospital, and the European Society of Radiology.
- With fresh capital, the firm plans to accelerate international expansion, enhance its AI-powered platform, and grow its global team across Boston, Paris, and Athens, making complex medical science more accessible, engaging, and actionable.
“Juisci transforms a massive volume of scientific data into actionable, dynamic insights for healthcare professionals. We believe it will become an indispensable ally to the medical community worldwide,” claims Guy Krief, Partner at Big Pi Ventures.
